Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously.
Year: 2003
Type: article
Study design: Clinical Trial
Source: PubMed
Institutions: Memorial Sloan Kettering Cancer Center, Cornell University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1812576394
